1,25-DIHYDROXYVITAMIN
D3 [1,25(OH)2D3] the active
form of vitamin D3, acts as an
immunomodulator in various
immune cells, according to a
study out of the Department of
Immunology, National Institute for
Research in Tuberculosis, in India.
The new work has demonstrated
that consequently this form of
vitamin D3 is able to act as an anti-inflammatory
by down-regulating
chemokine levels, which could be
beneficial to protect the host from
inflammation and tissue damage
during infection in pulmonary
tuberculosis.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.